Advances in the Lung Cancer Immunotherapy Approaches

Advances in the Lung Cancer Immunotherapy Approaches

Despite the progress in the comprehension of LC progression, risk, immunologic control, and treatment choices, it is still the primary cause of cancer-related death. LC cells possess a very low and heterogeneous antigenicity, which allows them to passively evade the anticancer defense of the immune...

Full description

Bibliographic Details
Main Authors: Hafiza Padinharayil, Reema Rose Alappat, Liji Maria Joy, Kavya V. Anilkumar, Cornelia M. Wilson, Alex George, Abilash Valsala Gopalakrishnan, Harishkumar Madhyastha, Thiyagarajan Ramesh, Ezhaveni Sathiyamoorthi, Jintae Lee, Raja Ganesan
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Vaccines
Subjects:
lung cancer
immunotherapy
epidemiology
immune profiling
vaccines: combinatorial therapy
cancer models
Online Access:https://www.mdpi.com/2076-393X/10/11/1963

Internet

https://www.mdpi.com/2076-393X/10/11/1963

Similar Items